「Viral hepatitis」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) (ページの作成:「==hepatitis virus== *viral hepatitis is 4th major infectious disease worldwide *virus hepatitis is still increasing year by year *>250 mil. people living with viral hepat…」) |
Vaccipedia.admin (トーク | 投稿記録) |
||
| (同じ利用者による、間の2版が非表示) | |||
| 1行目: | 1行目: | ||
| + | {{TM menu}} | ||
| + | |||
==hepatitis virus== | ==hepatitis virus== | ||
*viral hepatitis is 4th major infectious disease worldwide | *viral hepatitis is 4th major infectious disease worldwide | ||
| 21行目: | 23行目: | ||
==hep B== | ==hep B== | ||
| − | * | + | *family ''Hepadonavirus'' |
| + | *transmission route | ||
| + | **vertical | ||
| + | **horizontal | ||
| + | ***sexually transmitted | ||
| + | ***sharing needles | ||
| + | ===epidemiology=== | ||
| + | **240 mil. hep B carriers worldwide | ||
| + | **0.5 mil. death per year | ||
| + | *highly infectious; 10 virus copies are enough to infection | ||
| + | ===genotypes=== | ||
| + | *genotypes B and C prevalent in Asia | ||
| + | *A in Europe | ||
| + | ===acute hep B=== | ||
| + | *genotype A is increasing in Japan | ||
| + | **10% of genotype A carrier develope chronic carrier | ||
| + | *6.3% of hep B carrier are co-infected by hep C | ||
| + | ===treatment=== | ||
2021年5月30日 (日) 16:49時点における最新版
| Navigation Menu |
| General issues of Vaccine | |||||||
|---|---|---|---|---|---|---|---|
|
| General issues of Travel med. | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Immunology | |||||||
|---|---|---|---|---|---|---|---|
|
| Epi & Stats | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Virus | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| COVID-19 | |||||
|---|---|---|---|---|---|
|
| Bacteria | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Rickettsia | |||||
|---|---|---|---|---|---|
|
| Protozoa | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Fungi | |||||||
|---|---|---|---|---|---|---|---|
|
| Nematode (roundworm) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Trematode (fluke, distoma) | |||||||
|---|---|---|---|---|---|---|---|
|
| Cestode (tapeworm) | ||||||
|---|---|---|---|---|---|---|
|
| Medical Zoology | ||||||||
|---|---|---|---|---|---|---|---|---|
|
hepatitis virus
- viral hepatitis is 4th major infectious disease worldwide
- virus hepatitis is still increasing year by year
- >250 mil. people living with viral hepatitis
- hep B highly prevalent sub-Saharan children <5y/o
- virus hepatitis has added to one of SDGs in 2016
hep A
- food-borne, water-borne
- infection route in Japan
- mainly by raw oyster in HIV-negative
- mainly MSM in HIV-positive
hep E
- water-borne, contaminated meat-borne
- incompletely cooked deer meat, pig intestine or liver
- non-enveloped, positive-sense, single-stranded RNA virus
- endemic in East to Southeast Asia
- genotype 4 is strongly associated to fluminant hepatitis
- hep E vaccine has already established in China
hep B
- family Hepadonavirus
- transmission route
- vertical
- horizontal
- sexually transmitted
- sharing needles
epidemiology
- 240 mil. hep B carriers worldwide
- 0.5 mil. death per year
- highly infectious; 10 virus copies are enough to infection
genotypes
- genotypes B and C prevalent in Asia
- A in Europe
acute hep B
- genotype A is increasing in Japan
- 10% of genotype A carrier develope chronic carrier
- 6.3% of hep B carrier are co-infected by hep C